Overview of Vitiligo Research July - September 2014
- A second part of a review series on vitiligo covering disease classification, histopathology and treatments was published.
- An update on psycho-neuro-endocrine-immune connection in vitiligo and role of neuropeptides in control of regional immunity in skin diseases.
- Markedly reduced risk of melanoma and non-melanoma skin cancers was revealed in a study of large cohort of vitiligo patients.
- Epigallocatechin-3-gallate (EGCG), a green tee catechin with antioxidative properties, emerges as a potential preventive treatment for vitiligo.
- Results of Phase I clinical trial of afamelanotide showed that experimental treatment might be useful in treatment of vitiligo, especially in dark-skinned individuals
- Narrow-band ultraviolet B phototherapy is superior over oral minocycline in arresting vitiligo progression.
- Adipose-derived stem cells might improve efficiency of melanocyte transplantation in vitiligo treatment.
- Interleukin-33 emerges a possible player in vitiligo pathogenesis.
- Handheld phototherapy lamps lead to better compliance and overall effectiveness of light treatments.
This is a review of research results in the vitiligo field which were indexed in the PubMed database (www.ncbi.nlm.nih.gov/pubmed) for the period from July 2014 till September 2014. Abstracts of papers were retrieved from the PubMed database using the search term “vitiligo” with a filter set up to retrieve records with creation date between July 01, 2014 and September 30, 2014. Retrieved records were manually checked for a relevance to and significance for the field of vitiligo research. Fifty nine records were found to be relevant and of interest, and were included into this quarterly overview, under the following sections:
- Reviews & Comments
- Disease Management And Clinical Features
- Quality of life (QoL)
- Vitiligo triggers
- Case reports
- Understanding mechanisms of vitiligo pathogenesis
- Genetic studies
- Candidate biomarkers
- Mechanisms of treatments
- Methodological advancements
- Novel treatment modalities
- Clinical studies and trials
Download Review (PDF)
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
New York Vitiligo Community Meeting
Our next meeting will be after the World Vitiligo Day conference in Detroit on Thursday, July 20th, 2017, at 7PM - 8:30PM on the 11th floor of NYU's Ambulatory Care Ce...20 July 2017 19:00, 240 East 38th Street, New York, NY
Master Class On Vitiligo In Pediatric Age
will be held alongside “International Forum on Paediatric Dermatology”, which will take place in Rome (Italy), on October 5-7, 2017. This is an exciting opportunity t...06 October 2017 09:00, P.zza Giovanni Randaccio, 1 - Rome...
What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body. It doe...
What tests should be done?
No tests are usually necessary to make the diagnosis. The white patches may be seen more easily under Wood's light examination.
Can chemicals cause vitiligo?
Yes, certain chemicals can, indeed, induce or worsen vitiligo. Most commonly they include phenols, such as 4-tertiary-butyl phenol (4-TBP, found in adhesives) or 4-ter...
Is vitiligo contagious?
Vitiligo is NOT contagious. It cannot be passed on or caught from touching someone with vitiligo, shaking hands, swimming in the same pool, sharing towels, sitting nex...